These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30324424)

  • 61. Development of a Topical 48-H Release Formulation as an Anti-scarring Treatment for Deep Partial-Thickness Burns.
    Dorati R; Medina JL; DeLuca PP; Leung KP
    AAPS PharmSciTech; 2018 Jul; 19(5):2264-2275. PubMed ID: 29790019
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Model for the Analysis of Membrane-Type Dissolution Tests for Inhaled Drugs.
    Frenning G; van der Zwaan I; Franek F; Fransson R; Tehler U
    Mol Pharm; 2020 Jul; 17(7):2426-2434. PubMed ID: 32463245
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thixotropic property in pharmaceutical formulations.
    Lee CH; Moturi V; Lee Y
    J Control Release; 2009 Jun; 136(2):88-98. PubMed ID: 19250955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rheological estimation of the spreading characteristics of pharmaceutical semisolids.
    Boylan JC
    J Pharm Sci; 1967 Sep; 56(9):1164-9. PubMed ID: 6049705
    [No Abstract]   [Full Text] [Related]  

  • 65. D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel.
    Krtalić I; Radošević S; Hafner A; Grassi M; Nenadić M; Cetina-Čižmek B; Filipović-Grčić J; Pepić I; Lovrić J
    J Pharm Sci; 2018 Jun; 107(6):1562-1571. PubMed ID: 29421217
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemical and physicochemical characterization of petrolatums used in eye ointment formulations.
    De Muynck C; Lalljie SP; Sandra P; De Rudder D; Van Aerde P; Remon JP
    J Pharm Pharmacol; 1993 Jun; 45(6):500-3. PubMed ID: 8103095
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.
    Le Merdy M; Spires J; Lukacova V; Tan ML; Babiskin A; Xu X; Zhao L; Bolger MB
    Pharm Res; 2020 Nov; 37(12):245. PubMed ID: 33215336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems.
    Jug M; Hafner A; Lovrić J; Kregar ML; Pepić I; Vanić Ž; Cetina-Čižmek B; Filipović-Grčić J
    J Pharm Biomed Anal; 2018 Jan; 147():350-366. PubMed ID: 28720350
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low-surfactant microemulsions for enhanced topical delivery of poorly soluble drugs.
    Shalviri A; Sharma AC; Patel D; Sayani A
    J Pharm Pharm Sci; 2011; 14(3):315-24. PubMed ID: 21824447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Why does a hydrophilic drug permeate skin, although it is not soluble in white petrolatum?
    Ishii H; Todo H; Terao A; Hasegawa T; Akimoto M; Oshima K; Sugibayashi K
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1356-63. PubMed ID: 19832636
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Studies on ointment bases and ointments using the electron microscope. 4. Dispersity and structure-rheologic characteristics of various ointment bases].
    Christoff K; Marinoff M; Todorova P
    Pharmazie; 1972 May; 27(5):338-9. PubMed ID: 4647563
    [No Abstract]   [Full Text] [Related]  

  • 72. In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system.
    Deshmukh PK; Gattani SG
    Pharm Dev Technol; 2013; 18(4):950-6. PubMed ID: 22200332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Physicochemical properties of stomatological dressings on the basis of biodegradable nonionic polymers.
    Pluta J; Karolewicz B
    Polim Med; 2002; 32(3-4):20-9. PubMed ID: 12677648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
    Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate.
    Ahmad K; Win T; Jaffri JM; Edueng K; Taher M
    AAPS PharmSciTech; 2018 Jan; 19(1):371-383. PubMed ID: 28744617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel nanoscale-dispersed eye ointment for the treatment of dry eye disease.
    Zhang W; Wang Y; Lee BT; Liu C; Wei G; Lu W
    Nanotechnology; 2014 Mar; 25(12):125101. PubMed ID: 24571862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and Validation of Discriminatory In-vitro Release Method for Intramammary Drug Product.
    Helal NA; Martinez MN; Longstaff DG; Mohamed EM; Rahman Z; Khan MA; Nutan MTH
    Pharm Res; 2024 Jan; 41(1):129-139. PubMed ID: 37783927
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Viscosity of pharmacopeial multimolecular ointment vehicles and pharmaceutical availability of a model therapeutic agent.
    Piechota-Urbańska M; Kołodziejska J; Zgoda MM
    Polim Med; 2007; 37(2):3-19. PubMed ID: 17957945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.